PharmD Info

A forum for Indian Pharmacy Professionals

Indian Research Grants and Funding Agency Details for Getting National and International Scholarships, Fellowship, Travel Grants for PhD and Post Docs etc.
  • User avatar
#4499
Women Scientist Scheme - B (DST)

Women Scientist Scheme-B (WOS-B) is aimed at providing opportunities to women scientists and technologists who aim to return into the mainstream after a career break, with a focus on projects related to Science & Technology (S&T) interventions for societal benefit. Such project proposals should address a well-identified societal challenge and deliver possible solution(s) by way of development of viable technology/technique and/or lab-to-land technology transfer, its adaptation and scaling up.

Eligibility

• Women having qualifications in science & technology areas at the postgraduate level

• Age group: 27-57 years; Age relaxation of 5 years for candidates belonging to SC/ST/OBC- category and physically challenged candidates

• Minimum 2 years’ break after PhD award

• Not eligible — Women working as permanent employees

Support

• Stipend — ₹55,000 + HRA as per norms

• Total Project Cost (excluding HRA and Overhead) — ₹30 Lakhs

• Total project cost includes the above fellowship of Principal Investigator (PI), consumables, travel, contingencies and minor equipment but excluding HRA and overheads


Duration
The project is tenable for a maximum period of three years.


Deadline
The application opens once a year.


Website
https://dst.gov.in/scientific-programme ... s-programs
Similar Topics
Topics Statistics Last post
0 Replies 
97 Views
by Admin
07 Jan 2021, 16:37
0 Replies 
154 Views
by Admin
07 Jan 2021, 14:53
0 Replies 
135 Views
by Admin
07 Jan 2021, 14:40
0 Replies 
155 Views
by Admin
07 Jan 2021, 12:34
0 Replies 
136 Views
by Admin
07 Jan 2021, 12:42

*JOB DESCRIPTION: RESEARCH COORDINATOR* Dear Cand[…]

B Pharmacy PCI syllabus from First (I) to Eight (V[…]

There are different types of "recognitio[…]

Shycocan device is also known as Scalene Hyper-cha[…]

PharmD Info - Highlights